Located in Philadelphia, Temple University Hospital (TUH) is the tertiary hub of Temple University Health System (TUHS), which is composed of 3 hospitals, multidisciplinary satellite sites, urgent care centers and community outpatient offices. TUH is a 732-bed institution and is the chief clinical training site for the Lewis Katz School of Medicine at Temple University.
TUH performed the first heart transplant in the Philadelphia region back in 1984. Currently, it is the leader in lung transplantation, with 144 lung transplant surgeries, the most in the United States in 2018. In addition, TUH has a robust abdominal organ transplant program (kidney, liver, and pancreas) and heart transplant program, with 2018 averages of 70 and 20 surgeries, respectively.
TUH’s first pharmacy residency program was founded in 1969, and its graduates have gone on to successful careers in ambulatory care, critical care, infectious diseases, solid organ transplant, and academia, among others. There are currently 5 PGY1 pharmacy residents who gain clinical experience at both Temple University Hospital and Temple University Hospital – Jeanes Campus. The PGY2 Solid Organ Transplant pharmacy resident will have opportunities to gain clinical experience at both these campuses as well. This program will further enhance their clinical skills and knowledge through participation on the multidisciplinary transplant team. PGY2 pharmacy resident involvement will range from providing clinical services in the inpatient and outpatient settings, developing protocols and policies, educating pharmacy students and residents, and performing outcomes research.
Our mission is to provide safe, comprehensive, high quality, patient specific, pharmaceutical care in an environment of professionalism, respect, and integrity.
Statement of Purpose
PGY2 Solid Organ Transplant pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 Solid Organ Transplant residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 Solid Organ Transplant pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
The PGY2 Solid Organ Transplant Pharmacy Resident will have the opportunity to work in an academic tertiary care hospital providing them with exposure to all types of solid organ transplant populations. The complexity and diversity of the patient population will challenge the resident and expand their clinical and critical thinking skills in providing comprehensive care to solid organ transplant recipients. The strong relationship between transplant pharmacy and transplant surgery/medicine is integral in providing an educational and diverse experience to the resident while also providing the opportunity to establish collegial relationships with providers and other transplant staff. Transplant pharmacists at TUH are heavily involved in providing direct patient care to solid organ transplant recipients in both the inpatient and ambulatory settings, participating in outcomes research, protocol, policy, and guideline development, and educating pharmacy and transplant staff, students, and residents.
There is 1 PGY2 Solid Organ Transplant Pharmacy Residency position available each year.